The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adaptive response analysis of colorectal cancer cells to low-dose oxaliplatin as a tool to deciphering mechanisms of synergistic drug interaction.
 
Diego Tosi
Consulting or Advisory Role - Actelion (I); Biomarin (I); Brenus Pharma
Research Funding - Astellas Pharma; Bayer; Ipsen; Janssen
Patents, Royalties, Other Intellectual Property - I have a pending patent on a new drug combination for prostate cancer treatment
Travel, Accommodations, Expenses - Amicus Therapeutics (I); AstraZeneca; AstraZeneca; Biomarin (I); Ipsen; Janssen; Janssen; MSD; Nutricia (I); Pfizer
 
Mathilde Robin
No Relationships to Disclose
 
Marta Bini
No Relationships to Disclose
 
Candice Marchive
No Relationships to Disclose
 
Alexandre Djiane
No Relationships to Disclose
 
Lisa Heron-Milhavet
No Relationships to Disclose
 
Laurent Bréhélin
No Relationships to Disclose
 
Céline Gongora
Honoraria - Brenus Pharma
Consulting or Advisory Role - Brenus Pharma
Research Funding - Bayer; Ipsen